WallStreetZenWallStreetZen

NASDAQ: PRLD
Prelude Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Prelude Therapeutics earnings were -$127.2M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest PRLD earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$28.7M, down 11% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PRLD reported annual earnings of -$127.2M, with 4.4% growth. The next PRLD earnings date is May 5, 2025.

PRLD earnings history

Current Revenue
$0.0
Current Earnings
-$127.2M
Current Profit Margin
0%

PRLD Return on Equity

Current Company
-74.7%
Current Industry
-2%
Current Market
34.1%
PRLD's Return on Equity (-74.7%)... subscribe to Premium to read more.
High Return on Equity Performance

PRLD undefined

Current Company
-60.3%
Current Industry
-0.4%
PRLD is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when PRLD announces earnings.

PRLD undefined

Current Company
-84.85%
Current Industry
5.9%
PRLD's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PRLD vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
PRLD-$123.81M-$127.17MN/A-$1.68
AVTX-$38.16M-$35.13MN/A-$7.94
CYCC-$11.99M-$11.21MN/A-$2.09
FBIO-$24.85M-$55.89MN/A-$2.69
OKYO-$10.35M-$10.69MN/A-$0.38
View Top Biotech Stocks

PRLD earnings dates

Next earnings date
May 5, 2025

Prelude Therapeutics Earnings Reports & History FAQ

What were Prelude Therapeutics's earnings last quarter?

On PRLD's earnings call on Invalid Date, Prelude Therapeutics (NASDAQ: PRLD) reported Q4 2024 earnings per share (EPS) of -$0.38, up 19.15% year over year. Total PRLD earnings for the quarter were -$28.73 million. In the same quarter last year, Prelude Therapeutics's earnings per share (EPS) was -$0.47.

If you're new to stock investing, here's how to buy Prelude Therapeutics stock.

When does Prelude Therapeutics report earnings?

The next PRLD earnings call is Invalid Date. Add PRLD to your watchlist to be reminded of Prelude Therapeutics's next earnings date.

Is Prelude Therapeutics profitable or losing money?

As of the last Prelude Therapeutics earnings report, Prelude Therapeutics is currently losing money. Prelude Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$127.17 million, a 4.38% increase year over year.

What was PRLD's earnings growth in the past year?

As of Prelude Therapeutics's earnings date in Invalid Date, Prelude Therapeutics's earnings has grown year over year. PRLD earnings in the past year totalled -$127.17 million.

What are Prelude Therapeutics's earnings expectations?

The current EPS estimate for Prelude Therapeutics's earnings report in Invalid Date is -$0.48.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.